Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic

See also
Status	Clinical Trial	Phase
Terminated	`NCT03249272` - Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve	Phase 4
Recruiting	`NCT03846297` - Optimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy
Completed	`NCT02806479` - Hypertrophic Cardiomyopathy Pilot Study
Active, not recruiting	`NCT01225978` - Refining Information Technology Support for Genetics in Medicine	N/A
Completed	`NCT00001632` - Investigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease	N/A
Completed	`NCT00001534` - Long Term Effects of Enalapril and Losartan on Genetic Heart Disease	N/A
Enrolling by invitation	`NCT04050579` - OPIE in the Thin Interventricular Septum	N/A
Completed	`NCT03537183` - Will Elevated Left Ventricle Filling Pressures Decrease by a Group Exercise Program in Patients With Hypertrophic CardioMyopathy?	N/A
Completed	`NCT02590809` - Hypertrophic Cardiomyopathy Symptom Release by BX1514M	Phase 2
Completed	`NCT00001396` - Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy of Children With Obstructive Hypertrophic Cardiomyop...	Phase 1
Active, not recruiting	`NCT03723655` - A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM	Phase 2/Phase 3
Completed	`NCT05135871` - Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects	Phase 1
Completed	`NCT04129905` - Assessment of the Relations Between Endothelial and Venous Dysfunctions and Left Ventricular Obstruction in Genetic Hypertrophic Cardiomyopathies	N/A
Recruiting	`NCT03061994` - Metabolomic Study of All-age Cardiomyopathy	N/A
Completed	`NCT02234336` - Assessment of Wall Thickness in Hypertrophic Cardiomyopathy
Recruiting	`NCT00221832` - Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases	N/A
Not yet recruiting	`NCT03706001` - Efficacy of Psychotherapy for Improving Quality of Life in Patients With Hypertrophic Cardiomyopathy and Depression	N/A
Recruiting	`NCT06169358` - Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy
Not yet recruiting	`NCT04090437` - HCM-AF Ablation With ACUTUS	N/A
Completed	`NCT04402268` - Efficacy of Risk Assessment for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy

NCT number	NCT03496168
Study type	Interventional
Source	Bristol-Myers Squibb
Contact
Status	Completed
Phase	Phase 2
Start date	April 26, 2018
Completion date	November 9, 2023

Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER — PIONEER-OLE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms